People v. Cercado
REITERATIONFacts
The Antecedents: On November 5, 1999, PO2 Edgar C. Torres, acting as a poseur-buyer, along with a civilian confidential informant, allegedly purchased one (1) brick of marijuana from appellant Ferdinand Cercado y Mozada in Barangay Alipangpang, Pozorrubio, Pangasinan. The transaction involved a price of P2,000.00 for one (1) kilo of marijuana. After the transaction, PO2 Torres gave a pre-arranged signal, leading to the arrest of appellant by the back-up arresting officers. The boodle money and the brick of marijuana were recovered from appellant. Procedural History: The Regional Trial Court of Urdaneta, Pangasinan, Branch 46, found appellant guilty of violating Section 4, Article II of Republic Act No. 6425, as amended by R.A. No. 7659, and sentenced him to suffer the penalty of reclusion perpetua and to pay a fine of P1,000,000.00. The Petition: Appellant appealed the decision, assigning errors concerning the credibility of prosecution witnesses and the failure of the prosecution to prove his guilt beyond reasonable doubt, particularly regarding the negative allegation of lack of authority to sell marijuana.
Issue(s)
Whether the trial court erred in giving weight and credence to the testimonies of the prosecution witnesses. Whether the prosecution failed to prove the guilt of the accused beyond reasonable doubt, specifically concerning the lack of authority to sell marijuana.
Ruling
The Supreme Court affirmed the conviction of the appellant. The Court found no error in the trial court's appreciation of the evidence and upheld the conviction for illegal sale of marijuana.
Ratio Decidendi
On the credibility of prosecution witnesses: The Court found the testimonies of the prosecution witnesses regarding the buy-bust operation to be free from contradiction or fabrication and corroborated by evidence. In contrast, the appellant's defense of frame-up, involving unidentified men entering his house without a warrant, ransacking it, and demanding money, was deemed unpersuasive and uncorroborated. The Court noted that the defense of frame-up in drug cases requires strong and convincing evidence, which the appellant failed to provide. The Court also rejected the appellant's assertion that it was incredible to sell marijuana openly to strangers, citing the increasing daring of drug pushers. The Court held that the presentation of the confidential informant is not per se necessary if the sale of the prohibited drug has been adequately proven by other prosecution witnesses. The informant's testimony would be merely corroborative and cumulative if the elements of the offense are already established. His non-presentation does not create a hiatus in the prosecution's evidence. On proving the elements of illegal sale and the negative allegation of lack of authority: The Court reiterated that material to a prosecution for illegal sale of dangerous drugs is proof that the transaction or sale actually took place and the presentation of the corpus delicti. In this case, all elements were proven: a meeting of the minds between the buyer (PO2 Torres) and seller (appellant) at P2,000.00 per kilo, and the delivery of one (1) kilo of dried marijuana leaves. The Court clarified that the doctrine in People v. Pajenado has been modified. In People v. de los Reyes, it was held that the Dangerous Drugs Act applies generally, and no person is presumed authorized to sell such drugs. The accused claiming exemption must prove they fall under such exemption. The Court explained that where the negative of an issue does not permit direct proof or is more immediately within the accused's knowledge, the onus probandi rests upon the accused. The prosecution need only establish a prima facie case. The appellant, having been caught selling the drug and failing to produce any authority, did not meet this burden.
Main Doctrine
In prosecutions for illegal sale of dangerous drugs, the prosecution must prove the transaction or sale and present the corpus delicti. The accused claiming exemption from the general rule against selling dangerous drugs bears the burden of proving their authority or license to sell.